BR112022020143A2 - Teste de diagnóstico de patógeno - Google Patents

Teste de diagnóstico de patógeno

Info

Publication number
BR112022020143A2
BR112022020143A2 BR112022020143A BR112022020143A BR112022020143A2 BR 112022020143 A2 BR112022020143 A2 BR 112022020143A2 BR 112022020143 A BR112022020143 A BR 112022020143A BR 112022020143 A BR112022020143 A BR 112022020143A BR 112022020143 A2 BR112022020143 A2 BR 112022020143A2
Authority
BR
Brazil
Prior art keywords
diagnostic test
pathogen diagnostic
pathogen
pathogens
sequencing
Prior art date
Application number
BR112022020143A
Other languages
English (en)
Portuguese (pt)
Inventor
Kosuri Sriram
Matthew Jones Eric
Cooper Aaron
Jeanette Gasperini Molly
Original Assignee
Octant Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octant Inc filed Critical Octant Inc
Publication of BR112022020143A2 publication Critical patent/BR112022020143A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112022020143A 2020-04-06 2021-04-05 Teste de diagnóstico de patógeno BR112022020143A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063005996P 2020-04-06 2020-04-06
US202063062406P 2020-08-06 2020-08-06
US202163136449P 2021-01-12 2021-01-12
US202163154571P 2021-02-26 2021-02-26
PCT/US2021/025806 WO2021207091A1 (en) 2020-04-06 2021-04-05 Pathogen diagnostic test

Publications (1)

Publication Number Publication Date
BR112022020143A2 true BR112022020143A2 (pt) 2023-02-28

Family

ID=75675001

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022020143A BR112022020143A2 (pt) 2020-04-06 2021-04-05 Teste de diagnóstico de patógeno

Country Status (11)

Country Link
US (2) US12129523B2 (cg-RX-API-DMAC7.html)
EP (2) EP4133103A1 (cg-RX-API-DMAC7.html)
JP (1) JP7801240B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220164745A (cg-RX-API-DMAC7.html)
CN (1) CN115917002A (cg-RX-API-DMAC7.html)
AU (1) AU2021251703A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022020143A2 (cg-RX-API-DMAC7.html)
CA (1) CA3179579A1 (cg-RX-API-DMAC7.html)
IL (1) IL297033A (cg-RX-API-DMAC7.html)
MX (1) MX2022012516A (cg-RX-API-DMAC7.html)
WO (1) WO2021207091A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230019965A (ko) * 2020-06-22 2023-02-09 주식회사 씨젠 검체 내 타겟 핵산 서열 검출을 위한 준비물을 제공하는 방법
JP2024546168A (ja) * 2021-12-22 2024-12-17 オクタント,インク. レポータースクリーニングアッセイ用の品質管理
US12553093B1 (en) * 2025-03-26 2026-02-17 Wolf of Zion, Inc. Methods of detecting, identifying and quantifying wild spike protein and covid vaccine spike proteins

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582740B2 (en) 2003-04-17 2009-09-01 The Trustees Of Columbia University In The City Of New York Methods and kits for detecting SARS-associated coronavirus
WO2007100397A2 (en) * 2005-11-28 2007-09-07 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious contaminant viruses
CN101384730A (zh) * 2005-12-23 2009-03-11 阿尔维德医药技术公司 用于传染病和癌症检测的分子信标成像的方法和应用
US8354230B2 (en) 2007-12-21 2013-01-15 Quest Diagnostics Investments Inc. Multiplex detection assay for influenza and RSV viruses
EP2913402B1 (en) 2010-07-16 2017-10-18 Tocagen Inc. Retrovirus detection
MX345557B (es) 2011-07-06 2017-02-02 Quest Diagnostics Invest Inc Amplificacion y deteccion directa de patogenos virales y bacteriales.
WO2016057749A1 (en) * 2014-10-08 2016-04-14 Theranos, Inc. Methods and devices for real-time diagnostic testing (rdt) for ebola and other infectious diseases
EP3298169B1 (en) * 2015-05-18 2024-10-02 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
JP2017209036A (ja) * 2016-05-24 2017-11-30 東洋紡株式会社 改良されたウイルス検出方法
JP7167913B2 (ja) 2017-04-26 2022-11-09 東洋紡株式会社 ウイルスの検査方法およびウイルスの検査用キット
JP7796660B2 (ja) * 2020-03-09 2026-01-09 エフ. ホフマン-ラ ロシュ アーゲー 重症急性呼吸器症候群コロナウイルス2(sars-cov-2)、インフルエンザa及びインフルエンザbを検出するための組成物及び方法
CN111494616A (zh) * 2020-04-27 2020-08-07 重庆医科大学附属永川医院 一种新冠病毒免疫增强型基因疫苗及其制备方法

Also Published As

Publication number Publication date
WO2021207091A1 (en) 2021-10-14
US20220356535A1 (en) 2022-11-10
EP4133103A1 (en) 2023-02-15
IL297033A (en) 2022-12-01
JP7801240B2 (ja) 2026-01-16
JP2023520590A (ja) 2023-05-17
AU2021251703A1 (en) 2022-11-10
US12129523B2 (en) 2024-10-29
KR20220164745A (ko) 2022-12-13
CA3179579A1 (en) 2021-10-14
EP4286538A2 (en) 2023-12-06
MX2022012516A (es) 2023-01-19
US20250084492A1 (en) 2025-03-13
CN115917002A (zh) 2023-04-04
EP4286538A3 (en) 2024-03-20

Similar Documents

Publication Publication Date Title
BR112017010268A2 (pt) agente de ligação; composição de diagnóstico; kit de diagnóstico; métodos de diagnóstico de uma infecção bacteriana ou de diferenciação entre uma infecção bacteriana e uma infecção de viral; para descartar uma infecção bacteriana em um indivíduo; para descartar uma infecção viral em um indivíduo; para considerar uma infecção bacteriana em um indivíduo; para considerar uma infecção viral em um indivíduo; para distinguir entre uma infecção bacteriana ou mista e uma infecção viral em um indivíduo; para fornecer uma recomendação de tratamento para um indivíduo; para fornecer uma recomendação de teste de diagnóstico para um indivíduo; para descartar uma doença infecciosa; para identificação do tipo de infecção; e dispositivo para o diagnóstico de infecções bacterianas
CY1110948T1 (el) Μεθοδος διαγνωσης lawsonia intracellularis
CR20110567A (es) Dispositivos para diagnostico y metodos relacionados
CO2018009434A2 (es) Anticuerpos monoclonales de proteína ns1 anti-virus del dengue
EA201992748A1 (ru) Диагностические анализы для обнаружения, количественного определения и/или отслеживания микроорганизмов и других аналитов
MX2022012516A (es) Prueba diagnostica de patogenos.
MX2016005959A (es) Métodos para diagnosticar enfermedades infecciosas usando medio de adsorción.
EP4439102A4 (en) METHOD FOR DIAGNOSING THE CONDITION OF RECHARGEABLE BATTERIES AND CONDITION DIAGNOSTIC DEVICE
AR059361A1 (es) Dispositivo y metodos para detectar y cuantificar uno o mas agentes objetivos
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
BRPI1009276A2 (pt) painel, kit, dispositivo, método e meio legível por computador para teste diagnóstico rápido para uso na diagnose de malária e infecção bacteriana grave numa amostra de teste
BR112014026440A8 (pt) análises, métodos e aparelhos para avaliação de disrupção de rna.
MX377788B (es) Composiciones y metodos para la deteccion y analisis de tuberculosis micobacteriana.
CO2021000899A2 (es) Diagnóstico de la vaginosis bacteriana
TR201814812A2 (tr) Performans ölçme prosesi̇
BR112022008217A2 (pt) Métodos e dispositivos para sequenciamento
MX2013009209A (es) Metodo para analizar placa.
EP4386385A4 (en) IMMUNOLOGICAL ASSAY PROCEDURE, SAMPLE DILUENT AND IMMUNOCHROMATOGRAPHY KIT
WO2022217125A3 (en) Isothermal amplification-based detection of shrimp pathogens
ATE514794T1 (de) Zusammensetzungen und verfahren für den nachweis von enterokokken-nukleinsäuren
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
EP4408308C0 (en) ORTHOPEDIC PLANNING SYSTEMS, INSTRUMENTS AND REPAIR PROCEDURES
CN110741099A (zh) 评估个体的登革热病毒感染严重程度的方法、检测装置及检测试剂盒
ATE437957T1 (de) Schneller test auf peptidoglycanbasis zum nachweis der kontamination von blutplättchen mit bakterien